Cite
HARVARD Citation
Dou, Y. et al. (2020). Development of an IGF1R longevity variant mouse line using CRISPR/Cas9 genome editing. Trends in biomedical research. 3 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dou, Y. et al. (2020). Development of an IGF1R longevity variant mouse line using CRISPR/Cas9 genome editing. Trends in biomedical research. 3 (1), p. . [Online].